Evaluation of helical tomotherapy in the treatment of high-grade gliomas near critical structures

Tumori

Volumn 98, Issue 5, 2012, Pages 636-642

  Donato, Vittorio ^a   Caruso, Cristina ^a   Bressi, Caterina ^b   Pressello, Maria Cristina ^a   Salvati, Maurizio ^c   Delitala, Alberto ^a   Delfini, Roberto ^c  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Critical structures; Helical tomotherapy; High grade gliomas

Indexed keywords

TEMOZOLOMIDE;

ACUTE TOXICITY; ADULT; ARTICLE; BRAIN STEM; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; INTRACRANIAL TUMOR; MALE; MULTIMODALITY CANCER THERAPY; OPTIC CHIASM; OPTIC NERVE; PATIENT SAFETY; RADIATION DOSE; TOMOTHERAPY; TUMOR LOCALIZATION;

EID: 84872087273     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1190.13206     Document Type: Article

References (21)

1. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology, 30: 907-911, 1980.
2. Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA: Intensity-modulated radiotherapy in high-grade gliomas: Clinical and dosimetric results. Int J Radiat Oncol Biol Phys, 64: 892-897, 2006.
3. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J: Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys, 68: 858-863, 2007.
4. Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY: Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys, 67: 1135-1144, 2007.
5. Yartsev S, Kron T, Cozzi L, Fogliata A, Bauman G: Tomotherapy planning of small brain tumours. Radiother Oncol, 74: 49-52, 2005.
6. Shah AP, Langen KM, Ruchala KJ, Cox A, Kupelian PA, Meeks SL: Patient dose from megavoltage computed tomography imaging. Int J Radiat Oncol Biol Phy, 70: 1579-1587, 2008.
7. Mackie TR: History of tomotherapy. Phys Med Biol, 51: R427-253, 2006.
8. Welsh JS: Helical tomotherapy: a fascinating technological concept that has matured into clinical reality. Technol Cancer Res Treat, 7: 415-416, 2008.
9. Bichay T, Cao D, Orton CG: Point/counterpoint. Helical tomotherapy will ultimately replace linear accelerator based IMRT as the best way to deliver conformal radiotherapy. Med Phys, 35: 1625-1628, 2008.
10. Baltas D, Kolotas C, Geramani K, Mould RF, Ioannidis G, Kekchidi M, Zamboglou N: A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys, 40: 515-524, 1998.
11. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352: 987-996, 2005.
12. Donato V, Papaleo A, Castrichino A, Banelli E, Giangaspero F, Salvati M, Delfini R: Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide. Tumori, 93: 248-256, 2007.
13. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ, Curran WJ Jr: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys, 40: 51-55, 1998.
14. Curran WJ Jr, Scott CB, Nelson JS, Weinstein AS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Powlis WD: A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02. Cancer, 70: 2909-2917, 1992.
15. Urtasun RC, Kinsella TJ, Farnan N, DelRowe JD, Lester SG, Fulton DS: Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I-II study. Int J Radiat Oncol Biol Phys, 36: 1163-1167, 1996.
16. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys, 16: 1405-1409, 1989.
17. Massey V, Wallner KE: Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys, 18: 395-398, 1990.
18. Liang BC, Thornton AF Jr, Sandler HM, Greenberg HS: Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg, 75: 559-563, 1991.
19. Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G: Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. Int J Radiat Oncol Biol Phys, 73: 473-478, 2009.
20. Iuchi T, Hatano K, Narita Y, Kodama T, Yamaki T, Osato K: Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT. Int J Radiat Oncol Biol Phys, 64: 1317-1324, 2006.
21. Tsien C, Moughan J, Michalski JM, Gilbert MR, Purdy J, Simpson J, Kresel JJ, Curran WJ, Diaz A, Mehta MP; Radiation Therapy Oncology Group Trial 98-03: Radiation Therapy Oncology Group Trial 98-03. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03. Int J Radiat Oncol Biol Phys, 73: 699-708, 2009.